Hepsera is an antiviral tablet used to treat chronic hepatitis B virus (HBV). It works by reducing viral activity within liver cells and limiting its replication, helping protect the liver from progressive damage and delaying the development of complications such as cirrhosis or liver failure. It also contributes to improving liver function over the long term when the prescribed dose is adhered to.
Hepsera contains adefovir dipivoxil, which works by inhibiting the viral reverse transcriptase enzyme, thereby preventing the formation of new viral DNA. This halts the viral life cycle and reduces the viral load in the blood. The use of Hepsera is part of a treatment plan that may include periodic monitoring and laboratory tests to assess response. The medication should not be stopped suddenly except with the doctor's approval to avoid relapse of the virus or the occurrence of serious complications.